Oxidative stress in young subjects with acute myocardial infarction: evaluation at the initial stage and after 12

Rosalia LoPresti1, Anna Catania, Teresa D'Amico

  • 1Dipartimento di Medicina Interna, Malattie Cardiovascolari e Nefrourologiche, Università di Palermo, Policlinico-Via del Vespro 129, Palermo, Italy.

Insights

This study found that acute myocardial infarction patients have increased oxidative stress markers and decreased antioxidant status, which persisted even after 12 months. Smoking was linked to lower nitric oxide metabolites in these patients.

Area of Science:

  • Cardiology
  • Biochemistry
  • Oxidative Stress Research

Background:

  • Acute myocardial infarction (AMI) is a critical cardiovascular event.
  • Oxidative stress plays a significant role in the pathophysiology of AMI.
  • Assessing biomarkers of oxidative stress and antioxidant status is crucial for understanding AMI progression.

Purpose of the Study:

  • To evaluate thiobarbituric acid reactive substances (TBARS), total antioxidant status (TAS), and nitric oxide production (NOx) in patients with recent AMI.
  • To investigate the changes in these parameters over a 12-month period.
  • To explore the association of these biomarkers with cardiovascular risk factors and coronary lesion extent.

Main Methods:

  • Prospective study involving 105 patients with recent AMI.
  • Biomarker analysis included TBARS, TAS, and NOx (nitrite and nitrate) at baseline (T1) and 12 months (T2).
  • Patients were stratified by risk factors, number of risk factors, and coronary lesion severity.

Main Results:

  • At T1, AMI patients exhibited significantly elevated TBARS and NOx levels, and significantly decreased TAS compared to controls (implied).
  • After 12 months (T2), TBARS and NOx decreased, and TAS increased, but all parameters remained significantly altered.
  • Smoking was associated with lower NO metabolites in AMI patients with a single risk factor.

Conclusions:

  • Patients with recent AMI demonstrate persistent alterations in oxidative stress and antioxidant capacity markers 12 months post-event.
  • These findings highlight the long-term impact of AMI on redox balance.
  • Further research is warranted to explore therapeutic strategies targeting oxidative stress in AMI management.

Related Concept Videos

Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...